Immuron Limited (ASX:IMC)
Australia · Delayed Price · Currency is AUD 0.0400
-0.0040 (-9.09%)
May 29, 2026, 3:32 PM AEST
Immuron Market Cap
Immuron has a market cap or net worth of 13.07 million as of May 29, 2026. Its market cap has decreased by -18.91% in one year.
Market Cap
13.07M
Enterprise Value
3.27M
Revenue
7.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 13.07M, a decrease of -64.98%. That is a compound annual growth rate of -3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 13.07M | 11.50% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 26.42M |
| Algorae Pharmaceuticals | 23.27M |
| Proteomics International Laboratories | 22.30M |
| Neurotech International | 15.81M |
| Argenica Therapeutics | 15.41M |
| AdAlta | 11.95M |
| Cambium Bio | 11.89M |
| Bio-Gene Technology | 8.54M |